CTRI/2021/01/030318Other未知
A Single-Center, Open-Label, Prospective, Clinical Validation Study of TROPCHEK â?? a Novel, Non-Invasive Class C In-Vitro Point-Of-Care Diagnostic Medical Device for detection of Cardiac Troponins T and I in the Venous Blood
Rohit Srivastava0 个研究点目标入组 53 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- Other
- 发起方
- 入组人数
- 53
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •Leftover plasma from venous blood of suspected/ at-risk patients with ACS, COVID-19 and other conditions for which testing for cardiac troponins are requested by physicians.
- •a) Acute coronary syndrome
- •b) Acute respiratory infection
- •c) COVID-19
- •d) Pulmonary hypertension
- •e) Pulmonary embolus
- •f) Congestive heart failure
- •g) Coronary artery spasm
- •h) Tachyarrhythmias
- •i) Myocarditis
- •j) Kidney disease
- •k) Prolonged exercise
- •l) Trauma that injures the heart
- •m) Cardiomyopathy
- •n) Cardiac angioplasty/stenting
- •o) Heart defibrillation or electrical cardioversion
- •p) Open heart surgery
- •q) Radiofrequency ablation of the heart
- •r) Rhabdomyolysis and polymyositis
排除标准
- •a) Patients not willing to participate in the study
- •b) Specimen prepared incorrectly
- •c) Those with labelling problems
- •d) Temperature not maintained for specimen.
- •e) Samples received >4 hours after collection.
研究者
相似试验
已完成
不适用
A clinical study to determine the accuracy of pulse oximeters in measuring SpO2 as compared to SaO2 by co-oximeterCTRI/2022/03/041270Choicemmed Technology India Pvt Ltd15
招募中
不适用
A scientific study to understand the effect of three combined medicine in the Management of Postoperative Symptoms in Patients who Underwent Surgical Treatment for Anorectal DisordersCTRI/2020/11/029298Dr Niranjan Agarwal
已完成
3 期
Clinical Trial to assess efficacy of Parsana Acupressure Therapy plate in Type II Diabetes mellitus, Anxiety, Joint PaiCTRI/2023/09/057271PARSANA Health Centre Pvt Ltd.47
招募中
1 期
A clinical study to assess how safe and effective it is for subjects with hepatocellular carcinoma (HCC) to receive radiation therapy with TheraSphere followed by immunotherapy (durvalumab and tremelimumab treatment)Hepatocellular CarcinomaMedDRA version: 21.1Level: LLTClassification code: 10049010Term: Carcinoma hepatocellular Class: 10029104CTIS2023-508945-41-00Biocompatibles UK Limited107
已完成
Unknown
Safety and Efficacy of lip mask on female subjects with dry lips.CTRI/2023/12/060911DPKA Universal Consumer Ventures Private Limited60
